Terms: = Lymphoma AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH
143 results:
1. Anaplastic large cell lymphoma with ALK::atic fusion mimicking a histiocytic sarcoma debuting as an anterior thoracic soft tissue tumor with exceptional clinicopathological, morphological and molecular features.
García-Muñiz JA; Vilches-Cisneros N; Flores-Gutiérrez JP; Barboza-Quintana O
Thorac Cancer; 2024 May; 15(13):1103-1105. PubMed ID: 38523398
[TBL] [Abstract] [Full Text] [Related]
2. Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
Alzahrani K; Pasvolsky O; Wang Z; Milton DR; Tanner MR; Bashir Q; Srour S; Saini N; Lin P; Ramdial J; Nieto Y; Lee HC; Patel KK; Manasanch EE; Kebriaei P; Thomas SK; Weber DM; Orlowski RZ; Shpall EJ; Champlin R; Qazilbash MH
Br J Haematol; 2024 May; 204(5):1944-1952. PubMed ID: 38448009
[TBL] [Abstract] [Full Text] [Related]
3. Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL): A population-based paediatric study of the NHL-BFM study group.
Luedersen J; Stadt UZ; Richter J; Oschlies I; Klapper W; Rosenwald A; Kalinova M; Simonitsch-Klupp I; Siebert R; Zimmermann M; Qi M; Nakel J; Scheinemann K; Knörr F; Attarbaschi A; Kabickova E; Woessmann W; Damm-Welk C
Br J Haematol; 2024 May; 204(5):1894-1898. PubMed ID: 38279625
[TBL] [Abstract] [Full Text] [Related]
4. Long-term outcomes with HLX01 (HanliKang
Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Screening in Anaplastic lymphoma Kinase-Positive Anaplastic Large Cell lymphoma: Anaplastic lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
[TBL] [Abstract] [Full Text] [Related]
6. Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms.
Liu Y; Ho C; Yu W; Huang Y; Miller J; Gao Q; Syed M; Ma Y; Wang M; Maciag L; Petrova-Drus K; Zhu M; Yao J; Vanderbilt C; Durham B; Benhamida J; Ewalt MD; Dogan A; Roshal M; Nafa K; Arcila ME
J Mol Diagn; 2024 Mar; 26(3):168-178. PubMed ID: 38103591
[TBL] [Abstract] [Full Text] [Related]
7. An ultrahigh-performance liquid chromatography-tandem mass spectrometry method for quantification of methotrexate and 7-hydroxy-methotrexate and application for therapeutic drug monitoring in patients with central nervous system lymphoma.
Huo J; Zhang B; Zhang D; Zhu B; Zhao Z; Mei S
Biomed Chromatogr; 2024 Feb; 38(2):e5789. PubMed ID: 38037467
[TBL] [Abstract] [Full Text] [Related]
8. Impact of age on long-term relative survival benefit of radiotherapy for early-stage grade I-II follicular lymphoma from the SEER database (2000-2015).
Zhong Q; Liu Y; Wu Y; Liu X; Chen S; Chen B; Su F; Li G; Xu Y; Liu L; Chen F; Qi S; Li Y
Leuk Lymphoma; 2024 Mar; 65(3):312-322. PubMed ID: 37987687
[TBL] [Abstract] [Full Text] [Related]
9. Modification of Lugano criteria by pre-infusion tumor kinetics improves early survival prediction for patients with lymphoma under chimeric antigen receptor T-cell therapy.
Winkelmann M; Blumenberg V; Rejeski K; Quell C; Bücklein V; Ingenerf M; Unterrainer M; Schmidt C; Dekorsy FJ; Bartenstein P; Ricke J; von Bergwelt-Baildon M; Subklewe M; Kunz WG
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37880181
[TBL] [Abstract] [Full Text] [Related]
10. Endothelial-derived small extracellular vesicles support B-cell acute lymphoblastic leukemia development.
Huang D; Yuan Y; Cao L; Zhang D; Jiang Y; Zhang Y; Chen C; Yu Z; Xie L; Wei Y; Wan J; Zheng J
Cell Oncol (Dordr); 2024 Feb; 47(1):129-140. PubMed ID: 37751067
[TBL] [Abstract] [Full Text] [Related]
11. Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children's Cancer Group study ALL-2015.
Liu K; Shao J; Cai J; Tang J; Shen S; Xu F; Ren Y; Zhang A; Tian X; Lu X; Hu S; Hu Q; Jiang H; Zhou F; Liang C; Leung AWK; Zhai X; Li C; Fang Y; Wang Z; Wen L; Yang H; Wang N; Jiang H
Ann Hematol; 2023 Dec; 102(12):3431-3444. PubMed ID: 37550503
[TBL] [Abstract] [Full Text] [Related]
12. Activation recovery interval as an electrocardiographic repolarization index to detect doxorubicin-induced cardiotoxicity.
Kinoshita T; Onda N; Ohno R; Ikeda T; Sugizaki Y; Ohara H; Nakagami T; Yuzawa H; Shimada H; Shimizu K; Ikeda T
J Cardiol; 2023 Dec; 82(6):473-480. PubMed ID: 37506822
[TBL] [Abstract] [Full Text] [Related]
13. The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjögren's syndrome: a single-centre, retrospective cohort study.
Mayer M; Martinic M; Reihl-Crnogaj M; Anic B
Rheumatol Int; 2023 Nov; 43(11):2031-2036. PubMed ID: 37491526
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of the efficacy of gastric lymphoma treated with non-surgical therapy using oral and double contrast-enhanced gastric ultrasonography.
Wen Z; He X; Chen C; Sun J; Yin J; Wang T; Liu Z; Wang L; Yang N
Med Ultrason; 2023 Sep; 25(3):255-262. PubMed ID: 37369032
[TBL] [Abstract] [Full Text] [Related]
15. Risk of suicide in patients with cancer aged 75 years or more - Follow-up of over 400,000 individuals.
Michalek IM; Caetano Dos Santos FL; Wojciechowska U; Didkowska J
Maturitas; 2023 Sep; 175():107785. PubMed ID: 37348282
[TBL] [Abstract] [Full Text] [Related]
16. Germline genetic variations in methotrexate pathway are associated with pharmacokinetics, outcome, and toxicity in patients with primary central nervous system lymphoma.
Wu Z; Li Z; Qiu X; Zhong M; Ding T
Expert Rev Clin Pharmacol; 2023 Apr; 16(4):371-381. PubMed ID: 36946320
[TBL] [Abstract] [Full Text] [Related]
17. Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy.
Li M; Mi L; Wang C; Wang X; Zhu J; Qi F; Yu H; Ye Y; Wang D; Cao J; Hu D; Yang Q; Zhao D; Ma T; Song Y; Zhu J
BMC Med; 2022 Oct; 20(1):369. PubMed ID: 36280874
[TBL] [Abstract] [Full Text] [Related]
18. Disparities in Survival and Comorbidity Burden Between Asian and Native Hawaiian and Other Pacific Islander Patients With Cancer.
Taparra K; Qu V; Pollom E
JAMA Netw Open; 2022 Aug; 5(8):e2226327. PubMed ID: 35960520
[TBL] [Abstract] [Full Text] [Related]
19. SUMO Modification of Histone Demethylase KDM4A in Kaposi's Sarcoma-Associated Herpesvirus-Induced Primary Effusion lymphoma.
Yeh WW; Chen YQ; Yang WS; Hong YC; Kao S; Liu TT; Chen TW; Chang L; Chang PC
J Virol; 2022 Aug; 96(16):e0075522. PubMed ID: 35914074
[TBL] [Abstract] [Full Text] [Related]
20. Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular lymphoma and Diffuse Large B-Cell lymphoma.
Qu Z; Zhang T; Gao F; Gong W; Cui Y; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Li L; Wang X; Zhang H
Biomed Res Int; 2022; 2022():4379556. PubMed ID: 35655476
[TBL] [Abstract] [Full Text] [Related]
[Next]
